Roche and Blueprint extend collaboration with $1.7 billion cancer drug development and commercialisation deal
July 14, 2020Manufacturing and Production, Research and Development Blueprint Medicines, Cancer, Roche, pralsetinib
Roche and Blueprint Medicines have come together in a $1.7 billion development and commercialisation partnership focused on precision therapy pralsetinib …
Pfizer and BioNTech’s COVID-19 vaccines to have their development fast tracked by the FDA
July 14, 2020Manufacturing and Production, Research and Development COVID-19, Vaccine, coronavirus
The FDA has granted Pfizer and BioNTech’s COVID-19 vaccine candidates Fast Track status to speed up their development and review. …
Itolizumab “significantly reduced mortality” in hospitalised COVID-19 patients with respiratory distress, secures emergency use authorisation in India
July 13, 2020Research and Development, Sales and Marketing COVID-19, Itolizumab, coronavirus
Itolizumab, a drug currently being developed by biotech firm Equillium for autoimmune and inflammatory disorders, “significantly reduced mortality” in hospitalised …
WHO reports record daily increase in global COVID-19 cases
July 13, 2020Sales and Marketing COVID-19, coronavirus
The World Health Organization reported the largest daily increase in COVID-19 cases since the pandemic began. Over the weekend there …
Russia claims it has completed the first human trial for COVID-19 vaccine
July 13, 2020Sales and Marketing COVID-19, coronavirus, vaccines
Russia has become the first country to complete a COVID-19 vaccine trial on humans, according to the Russian News Agency. …
Remdesivir cuts death risk by 62% in coronavirus patients, new study shows
July 13, 2020Sales and Marketing COVID-19, coronavirus
Gilead’s remdesivir reduced the risk of death in 62% of severe COVID-19 patients, according to a new study. The company …
Roche’s Tecentriq fails to hit main Phase 3 goal in front-line ovarian cancer
July 13, 2020Research and Development, Sales and Marketing Genentech, Roche, ovarian cancer, tecentriq
Roche subsidiary Genentech has revealed that its immunotherapy Tecentriq (atezolizumab), combined with Avastin (bevacizumab), paclitaxel and carboplatin, fell short of …
Dr Edwin Moses appointed as Chairman of the Board of Sensorin
July 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Sensorin have appointed Dr Edwin Moses as the Chairman of its Board of Directors Moses joins from his previous role …
New data shows Gilead’s remdesivir “potently inhibited” SARS-CoV-2 in human lung cell cultures
July 10, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir
New findings published from researchers at Vanderbilt University Medical Center (VUMC) at the University of North Carolina, as well as …
Scientists warn of brain damage linked to COVID-19
July 10, 2020Medical Communications COVID-19, Neurological, coronavirus
COVID-19 could lead to a wave of brain damage in people who were infected with the virus. Experts at the …
Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance
July 10, 2020Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma
Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …
The World Health Organization says COVID-19 can linger in the air indoors
July 10, 2020Medical Communications COVID, COVID-19, WHO, coronavirus
The World Health Organization has recoginised that COVID-19 can be transmitted indoors by droplets in the air, reversing its previous …
Top Ten most popular articles on Pharmafile.com this week
July 10, 2020Medical Communications coronavirus, covid19, top 10
The World Health Organization features prominently in the news this week, as it discontinued trials into the viability of hydroxychloroquine, …
J&J under fire from 170 nonprofits to halt baby powder sales worldwide because it contains asbestos
July 9, 2020Sales and Marketing Cancer, J&J, JJ, pharma, talc
In the latest chapter in Johnson & Johnson’s talc-related woes, the company is being pressured by group of over 170 …
NICE recommends Takeda’s Adcetris for previously untreated systemic anaplastic large cell lymphoma
July 9, 2020Sales and Marketing Adcentris, NICE, Takeda, UK
NICE has announced it has recommended Takeda’s Adcetris (brentuximab vedotin), in combination with cyclophosphamide, doxorubicin and prednisone (CHP), for use …
Regeneron seals $450m BARDA contract to scale up production of its COVID-19 vaccine
July 9, 2020Manufacturing and Production, Sales and Marketing BARDA, Operation Warp Speed, Regeneron, US, vaccine COVID-19
Regeneron has revealed that REGN-COV2, its two-antibody vaccine for the treatment and prevention of COVID-19, has been awarded a manufacturing …
Pakistani government takes away pharmaceutical companies’ power to raise drug prices
July 9, 2020Business Services Pakistan, Pharmaceutical Companies
The government of Pakistan has decided to abolish all sections of the Drugs Pricing Policy, which will take away pharmaceutical …
Majority of people who test positive for COVID-19 have no symptoms, according to ONS study
July 9, 2020Business Services COVID-19, coronavirus, testing
Most people who test positive for COVID-19 do not have symptoms of the virus when tested, according to the Office …
European green light for Lynparza in germline BRCA-mutated metastatic pancreatic cancer
July 8, 2020Research and Development, Sales and Marketing AstraZeneca, Cancer, Europe, MSD, lynparza
The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …
COVID-19 impact on England’s cancer services could lead to 35,000 excess deaths
July 8, 2020Research and Development COVID-19, Cancer, England, coronavirus
New data emerging from DATA-CAN: The Health Data Research Hub for Cancer has shone a light on the potential toll …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
